We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Non-Surgical Bypass Without Anesthesia

By HospiMedica staff writers
Posted on 02 Jul 2001
In a new procedure that could radically change the way coronary artery bypass procedures are performed, doctors used an ultrasound-guided catheter to redirect blood flow from a diseased coronary artery into a coronary vein that over time widened and transformed itself into an artery. More...
The procedure requires no anesthesia and takes only several hours.

Following catheter insertion, doctors advanced a needle from inside the catheter through the wall of the artery and into the adjacent vein. They then threaded a thin guidewire through the needle, withdrew the catheter and needle, and inserted a small balloon to follow the guidewire and widen the channel. A stent-like device was inserted to keep the channel open for blood flow. Directly above the new channel, the vein was blocked so that blood from the artery would be redirected through the vein toward the heart.

The surgery was performed by Dr. Stephen Oesterle, a cardiologist at Massachusetts General Hospital (Boston, USA), and colleagues on a patient in Germany. More than a year has passed since the surgery, and the patient, who had severe angina before the procedure, to date remains pain free. The new treatment, called percutaneous in-situ coronary venous arterialization (PICVA), is intended for patients who cannot have traditional angioplasty or bypass surgery because of diffuse coronary artery disease. Doctors caution that while the results were encouraging, they are based on a single case and the long-term outcome is unknown.


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammo DR Retrofit Solution
DR Retrofit Mammography
Pressure Guidewire
SavvyWire
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.